Cargando…

Treatment Costs of Colorectal Cancer by Sex and Age: Population-Based Study on Health Insurance Data from Germany

SIMPLE SUMMARY: Screening for colorectal cancer (CRC) has considerably contributed to declining CRC incidence and mortality rates in Germany over the last two decades. However, evidence on the cost-effectiveness of this public health remains scarce, mostly due to the lack of detailed sex- and age-sp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heisser, Thomas, Simon, Andreas, Hapfelmeier, Jana, Hoffmeister, Michael, Brenner, Hermann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367511/ https://www.ncbi.nlm.nih.gov/pubmed/35954499 http://dx.doi.org/10.3390/cancers14153836

Ejemplares similares

Age-specific sequence of colorectal cancer screening options in Germany: A model-based critical evaluation
por: Heisser, Thomas, et al.
Publicado: (2020)

Indications of substantial delay of colorectal cancer diagnoses due to COVID-19 in Germany
por: Brenner, Hermann, et al.
Publicado: (2022)

Impact of demographic changes and screening colonoscopy on long-term projection of incident colorectal cancer cases in Germany: A modelling study
por: Heisser, Thomas, et al.
Publicado: (2022)

Personalized Initial Screening Age for Colorectal Cancer in Individuals at Average Risk
por: Chen, Xuechen, et al.
Publicado: (2023)

When gold standards are not so golden: prevalence bias in randomized trials on endoscopic colorectal cancer screening
por: Brenner, Hermann, et al.
Publicado: (2023)

Consistent Major Differences in Sex- and Age-Specific Diagnostic Performance among Nine Faecal Immunochemical Tests Used for Colorectal Cancer Screening
por: Gies, Anton, et al.
Publicado: (2021)

Beyond familial risk: deriving risk‐adapted starting ages of screening among people with a family history of colorectal cancer
por: Chen, Xuechen, et al.
Publicado: (2023)

Utilisation of Colorectal Cancer Screening Tests in European Countries by Type of Screening Offer: Results from the European Health Interview Survey
por: Cardoso, Rafael, et al.
Publicado: (2020)

Outcomes at follow-up of negative colonoscopy in average risk population: systematic review and meta-analysis
por: Heisser, Thomas, et al.
Publicado: (2019)

Strongly Divergent Impact of Adherence Patterns on Efficacy of Colorectal Cancer Screening: The Need to Refine Adherence Statistics
por: Heisser, Thomas, et al.
Publicado: (2021)

A single measurement of fecal hemoglobin concentration outperforms polygenic risk score in colorectal cancer risk assessment
por: Niedermaier, Tobias, et al.
Publicado: (2023)

Prevalence of Colorectal Neoplasia 10 or More Years After a Negative Screening Colonoscopy in 120 000 Repeated Screening Colonoscopies
por: Heisser, Thomas, et al.
Publicado: (2023)

The Effects of Different Invitation Schemes on the Use of Fecal Occult Blood Tests for Colorectal Cancer Screening: Systematic Review of Randomized Controlled Trials
por: Gruner, Laura F., et al.
Publicado: (2021)

Impact of Reducing Intake of Red and Processed Meat on Colorectal Cancer Incidence in Germany 2020 to 2050—A Simulation Study
por: Niedermaier, Tobias, et al.
Publicado: (2023)

Sex Differences in Colorectal Cancer Survival: Population-Based Analysis of 164,996 Colorectal Cancer Patients in Germany
por: Majek, Ondrej, et al.
Publicado: (2013)

Medication Adherence and Healthcare Costs in Chronically Ill Patients Using German Claims Data
por: Wendl, Johannes, et al.
Publicado: (2023)

Estimating Colorectal Cancer Treatment Costs: A Pragmatic Approach Exemplified by Health Insurance Data from Germany
por: Haug, Ulrike, et al.
Publicado: (2014)

Fecal Immunochemical Tests Detect Screening Participants with Multiple Advanced Adenomas Better than T1 Colorectal Cancers
por: Gies, Anton, et al.
Publicado: (2021)

Colorectal Cancer Risk by Genetic Variants in Populations With and Without Colonoscopy History
por: Guo, Feng, et al.
Publicado: (2021)

Colorectal cancer screening: the time to act is now
por: Brenner, Hermann, et al.
Publicado: (2015)

Hormone replacement therapy, body mass, and the risk of colorectal cancer among postmenopausal women from Germany
por: Hoffmeister, M, et al.
Publicado: (2007)

Vitamin D Status, Cdx2 Genotype, and Colorectal Cancer Survival: Population-Based Patient Cohort
por: Gwenzi, Tafirenyika, et al.
Publicado: (2023)

Red and Processed Meat Intake, Polygenic Risk Score, and Colorectal Cancer Risk
por: Chen, Xuechen, et al.
Publicado: (2022)

Outcomes and costs of ureteroscopy, extracorporeal shockwave lithotripsy, and percutaneous nephrolithotomy for the treatment of urolithiasis: an analysis based on health insurance claims data in Germany
por: Schulz, Claudia, et al.
Publicado: (2021)

Associations of smoking with early- and late-onset colorectal cancer
por: Li, Hengjing, et al.
Publicado: (2023)

Reproductive Factors and Colorectal Cancer Risk: A Population-Based Case-Control Study
por: Amitay, Efrat L, et al.
Publicado: (2022)

Gender differences in colorectal cancer: implications for age at initiation of screening
por: Brenner, H, et al.
Publicado: (2007)

Trends of population-based breast cancer survival in Germany and the US: Decreasing discrepancies, but persistent survival gap of elderly patients in Germany
por: Holleczek, Bernd, et al.
Publicado: (2012)

Flexible sigmoidoscopy in colorectal cancer screening: implications of different colonoscopy referral strategies
por: Niedermaier, Tobias, et al.
Publicado: (2018)

Health and life insurance-related problems in very long-term cancer survivors in Germany: a population-based study
por: Thong, Melissa S. Y., et al.
Publicado: (2021)

Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies
por: Brenner, Hermann, et al.
Publicado: (2014)

Expected long-term impact of screening endoscopy on colorectal cancer incidence: a modelling study
por: Brenner, Hermann, et al.
Publicado: (2016)

Multimorbidity patterns in the working age population with the top 10% medical cost from exhaustive insurance claims data of Japan Health Insurance Association
por: Nishida, Yuki, et al.
Publicado: (2023)

Self-Reported Lower Gastrointestinal Endoscopy Use and Changes in Colorectal Cancer Mortality Rates in European Countries
por: Chen, Chen, et al.
Publicado: (2020)

Whole blood DNA methylation aging markers predict colorectal cancer survival: a prospective cohort study
por: Gào, Xīn, et al.
Publicado: (2020)

Cost-effectiveness of Colorectal Cancer Screening
por: Lansdorp-Vogelaar, Iris, et al.
Publicado: (2011)

Vitamin D supplementation to the older adult population in Germany has the cost‐saving potential of preventing almost 30 000 cancer deaths per year
por: Niedermaier, Tobias, et al.
Publicado: (2021)

Should colorectal cancer screening start at the same age in European countries? Contributions from descriptive epidemiology
por: Brenner, H, et al.
Publicado: (2008)

Survival of patients with symptom- and screening-detected colorectal cancer
por: Brenner, Hermann, et al.
Publicado: (2016)

Association of Overweight, Obesity, and Recent Weight Loss With Colorectal Cancer Risk
por: Mandic, Marko, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j1b6ad971t7c20c53puovi8ioh